Annual CFF
N/A
31 December 2023
Summary:
Traws Pharma annual cash flow from financing activities is not available.TRAW Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFF
$0.00
-$14.00 M-100.00%
30 September 2024
Summary:
Traws Pharma quarterly cash flow from financing activities is currently $0.00, with the most recent change of -$14.00 million (-100.00%) on 30 September 2024. Over the past year, it has stayed the same.TRAW quarterly CFF is now -100.00% below its all-time high of $79.86 million, reached on 01 September 2013.TRAW Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFF
$14.00 M
$0.000.00%
30 September 2024
Summary:
Traws Pharma TTM cash flow from financing activities is currently $14.00 million, unchanged on 30 September 2024. Over the past year, it has increased by +$14.00 million (+100.00%). TRAW TTM CFF is now -82.79% below its all-time high of $81.36 million, reached on 01 June 2014.TRAW TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TRAW Cash From Financing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | 0.0% | +100.0% |
| 3 y3 years | - | +100.0% | -74.8% |
| 5 y5 years | - | -100.0% | -47.5% |
TRAW Cash From Financing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -100.0% | +100.0% | -74.8% | |||
| 5 y | 5 years | -100.0% | +100.0% | -75.0% | |||
| alltime | all time | -100.0% | +100.0% | -82.8% |
Traws Pharma Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $0.00(-100.0%) | $14.00 M(0.0%) |
| June 2024 | - | $14.00 M(>+9900.0%) | $14.00 M(>+9900.0%) |
| Sept 2023 | - | $0.00(0.0%) | $0.00(0.0%) |
| June 2023 | - | $0.00(-100.0%) | $0.00(-100.0%) |
| Dec 2021 | $55.56 M(+187.0%) | -$35.00 K(-100.2%) | $55.56 M(-0.6%) |
| Sept 2021 | - | $19.94 M(>+9900.0%) | $55.87 M(+44.6%) |
| June 2021 | - | $7000.00(-100.0%) | $38.65 M(-3.9%) |
| Mar 2021 | - | $35.64 M(>+9900.0%) | $40.22 M(+107.8%) |
| Dec 2020 | $19.36 M(-27.4%) | $279.00 K(-89.7%) | $19.36 M(-54.3%) |
| Sept 2020 | - | $2.72 M(+71.9%) | $42.33 M(-0.6%) |
| June 2020 | - | $1.58 M(-89.3%) | $42.58 M(+2.9%) |
| Mar 2020 | - | $14.78 M(-36.4%) | $41.39 M(+55.3%) |
| Dec 2019 | $26.65 M(-25.3%) | $23.25 M(+683.3%) | $26.65 M(+685.4%) |
| Sept 2019 | - | $2.97 M(+659.3%) | $3.39 M(+700.2%) |
| June 2019 | - | $391.00 K(+1084.8%) | $424.00 K(-98.4%) |
| Mar 2019 | - | $33.00 K(>+9900.0%) | $26.95 M(-24.4%) |
| Dec 2018 | $35.66 M(+460.6%) | $0.00(0.0%) | $35.66 M(-2.8%) |
| Sept 2018 | - | $0.00(-100.0%) | $36.70 M(0.0%) |
| June 2018 | - | $26.92 M(+207.9%) | $36.70 M(+143.7%) |
| Mar 2018 | - | $8.74 M(+738.1%) | $15.06 M(+136.8%) |
| Dec 2017 | $6.36 M | $1.04 M(>+9900.0%) | $6.36 M(+19.6%) |
| Sept 2017 | - | $0.00(-100.0%) | $5.32 M(-74.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2017 | - | $5.28 M(>+9900.0%) | $21.13 M(+33.3%) |
| Mar 2017 | - | $40.00 K(-4100.0%) | $15.85 M(-9.0%) |
| Dec 2016 | $17.42 M(+133.4%) | -$1000.00(-100.0%) | $17.42 M(-13.2%) |
| Sept 2016 | - | $15.81 M(>+9900.0%) | $20.07 M(+123.7%) |
| June 2016 | - | $1000.00(-99.9%) | $8.97 M(-1.1%) |
| Mar 2016 | - | $1.61 M(-39.2%) | $9.07 M(+21.6%) |
| Dec 2015 | $7.46 M(+410.2%) | $2.65 M(-43.9%) | $7.46 M(+40.0%) |
| Sept 2015 | - | $4.71 M(+4432.7%) | $5.33 M(+697.2%) |
| June 2015 | - | $104.00 K(>+9900.0%) | $669.00 K(+9.7%) |
| Mar 2015 | - | $0.00(-100.0%) | $610.00 K(-58.3%) |
| Dec 2014 | $1.46 M(-98.2%) | $515.00 K(+930.0%) | $1.46 M(-5.6%) |
| Sept 2014 | - | $50.00 K(+11.1%) | $1.55 M(-98.1%) |
| June 2014 | - | $45.00 K(-94.7%) | $81.36 M(+0.1%) |
| Mar 2014 | - | $853.00 K(+41.7%) | $81.31 M(+1.1%) |
| Dec 2013 | $80.46 M(+3.9%) | $602.00 K(-99.2%) | $80.46 M(-0.8%) |
| Sept 2013 | - | $79.86 M(>+9900.0%) | $81.11 M(+24.0%) |
| June 2013 | - | $0.00(-100.0%) | $65.40 M(-11.4%) |
| Mar 2013 | - | $6000.00(-99.5%) | $73.83 M(-4.7%) |
| Dec 2012 | $77.46 M(+691.6%) | $1.25 M(-98.1%) | $77.46 M(+1.6%) |
| Sept 2012 | - | $64.15 M(+661.4%) | $76.21 M(+531.8%) |
| June 2012 | - | $8.43 M(+131.6%) | $12.06 M(+231.6%) |
| Mar 2012 | - | $3.64 M | $3.64 M |
| Dec 2011 | $9.79 M | - | - |
FAQ
- What is the all time high annual CFF for Traws Pharma?
- What is Traws Pharma quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Traws Pharma?
- What is Traws Pharma quarterly CFF year-on-year change?
- What is Traws Pharma TTM cash flow from financing activities?
- What is the all time high TTM CFF for Traws Pharma?
- What is Traws Pharma TTM CFF year-on-year change?
What is the all time high annual CFF for Traws Pharma?
Traws Pharma all-time high annual cash flow from financing activities is $80.46 M
What is Traws Pharma quarterly cash flow from financing activities?
The current quarterly CFF of TRAW is $0.00
What is the all time high quarterly CFF for Traws Pharma?
Traws Pharma all-time high quarterly cash flow from financing activities is $79.86 M
What is Traws Pharma quarterly CFF year-on-year change?
Over the past year, TRAW quarterly cash flow from financing activities has changed by $0.00 (0.00%)
What is Traws Pharma TTM cash flow from financing activities?
The current TTM CFF of TRAW is $14.00 M
What is the all time high TTM CFF for Traws Pharma?
Traws Pharma all-time high TTM cash flow from financing activities is $81.36 M
What is Traws Pharma TTM CFF year-on-year change?
Over the past year, TRAW TTM cash flow from financing activities has changed by +$14.00 M (+100.00%)